Losidar 50 mg filmom obložene tablete Kroasia - Kroasia - HALMED (Agencija za lijekove i medicinske proizvode)

losidar 50 mg filmom obložene tablete

mylan hrvatska d.o.o., koranska 2, zagreb - losartanum - filmom obložena tableta - 50 mg - urbroj: svaka filmom obložena tableta sadrži 50 mg losartankalija

Složena otopina natrijevog laktata, otopina za infuziju (Hartmannova otopina) Kroasia - Kroasia - HALMED (Agencija za lijekove i medicinske proizvode)

složena otopina natrijevog laktata, otopina za infuziju (hartmannova otopina)

b. braun adria d.o.o., hondlova 2/9, zagreb - natrijev klorid kalijev klorid kalcijev klorid dihidrat natrijev laktat, otopina - otopina za infuziju - 6,0 g + 0,40 g + 0,27 g + 6,24 g - urbroj: 1000 ml otopine sadrži 6,0 g natrijevog klorida, 0,40 g kalijevog klorida, 0,27 g kalcijevog klorida dihidrata i 6,24 g natrijevog laktata, otopine

Cosopt PF 20 mg/ml + 5 mg/ml kapi za oko, otopina u jednodoznom spremniku Kroasia - Kroasia - HALMED (Agencija za lijekove i medicinske proizvode)

cosopt pf 20 mg/ml + 5 mg/ml kapi za oko, otopina u jednodoznom spremniku

santen oy, niittyhaankatu 20, tampere, finska - dorzolamidklorid timololmaleat - kapi za oko, otopina u jednodoznom spremniku - 20 mg/ml + 5 mg/ml - urbroj: 1 ml sadrži 20 mg dorzolamida u obliku dorzolamidklorida i 5 mg timolola u obliku timololmaleata

Tienam 500 mg/500 mg prašak za otopinu za infuziju Kroasia - Kroasia - HALMED (Agencija za lijekove i medicinske proizvode)

tienam 500 mg/500 mg prašak za otopinu za infuziju

merck sharp & dohme d.o.o., ivana lučića 2a, zagreb - imipenemum, cilastatinum - prašak za otopinu za infuziju - 500 mg/500 mg - urbroj: jedna bočica sadrži imipenem hidrat što odgovara 500 mg imipenema bezvodnog i cilastatinnatrij što odgovara 500 mg cilastatina

Zotramid 75 mg/650 mg tablete Kroasia - Kroasia - HALMED (Agencija za lijekove i medicinske proizvode)

zotramid 75 mg/650 mg tablete

pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - tramadolklorid paracetamol - tableta - 75 mg + 650 mg - urbroj: jedna tableta sadrži 75 mg tramadolklorida i 650 mg paracetamola

Dupixent Uni Eropa - Kroasia - EMA (European Medicines Agency)

dupixent

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenti za dermatitis, isključujući kortikosteroide - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Palynziq Uni Eropa - Kroasia - EMA (European Medicines Agency)

palynziq

biomarin international limited - pegvaliase - phenylketonurias - ostali prehrambeni proizvodi i proizvodi metabolizma - palynziq indiciran za liječenje bolesnika s fenilketonurija (pku) u dobi od 16 godina i stariji, koji imaju neprimjeren kontrolu fenilalanin u krvi (nivo fenilalanin u krvi više od 600 мкмоль/l), bez obzira na do upravljanja dostupne mogućnosti liječenja .

ChondroCelect Uni Eropa - Kroasia - EMA (European Medicines Agency)

chondrocelect

tigenix n.v. - karakterizirane održive autologne stanice hrskavice eksprimiraju ex vivo eksprimirajući specifične markere proteine - bolesti hrskavice - ostali lijekovi za poremećaje mišićno-koštanog sustava - popravak oštećenja jednog simptomatsko hrskavice kondila bedrene koljena (international hrskavice repair society [icrs] stupnja iii ili iv) u odraslih. polaznik asimptomatskih lezija hrskavice (ПВК klase i ili ii) mogu biti prisutni. demonstracija efikasnosti temelji se na randomizirana kontrolirana studija o proceni efikasnosti chondrocelect u bolesnika s porazom od 1 do 5 cm2.